Dong-Xu He
Overview
Explore the profile of Dong-Xu He including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
167
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sun Z, Yu T, Ma Y, Ma Q, Jiao Y, He D, et al.
World J Clin Cases
. 2020 Apr;
8(7):1232-1240.
PMID: 32337197
Background: Depression is common in patients with myocardial infarction and has been independently associated with adverse outcomes. However, the association between depression and myocardial injury on cardiac magnetic resonance (CMR)...
2.
Lu C, Wu X, Zhang G, Gu X, Ma X, He D
Eur J Cancer Prev
. 2018 Mar;
27(4):418-424.
PMID: 29557800
Cancer is one of the most important health problems today; therefore, many researchers are focusing on exploring the mechanisms underlying its development and treatment. The field of cancer epigenetics has...
3.
He D, Wu X, Lu C, Gu X, Zhang G, Ma X, et al.
Oncol Rep
. 2017 Oct;
38(6):3392-3402.
PMID: 29039577
The expression of estrogen receptor α (ER) in breast cancers may be indicative of a favorable prognosis and most of these cancers respond to anti-estrogens or aromatase inhibitors. However, ER-positive...
4.
He D, Gu F, Wu J, Gu X, Lu C, Mao A, et al.
Clin Sci (Lond)
. 2016 Sep;
130(24):2267-2276.
PMID: 27653744
Chemotherapeutic response is critical for the successful treatment and good prognosis in cancer patients. In this study, we analysed the gene expression profiles of preoperative samples from oestrogen receptor (ER)-negative...
5.
He D, Zhang G, Gu X, Mao A, Lu C, Jin J, et al.
Int J Oncol
. 2016 Sep;
49(4):1695-1703.
PMID: 27633960
Long non-coding RNAs (lncRNAs) are involved in cancer progression. In the present study, we analyzed the lncRNA profiles in adriamycin-resistant and -sensitive breast cancer cells and found a group of...
6.
He D, Gu F, Gao F, Hao J, Gong D, Gu X, et al.
Sci Rep
. 2016 Apr;
6:24706.
PMID: 27094684
Cancer chemoresistance is regulated by complex genetic and epigenetic networks. In this study, the features of gene expression, methylation, and microRNA (miRNA) expression were investigated with high-throughput sequencing in human...
7.
He D, Ma X
Onco Targets Ther
. 2016 Apr;
9:1077-84.
PMID: 27042100
The incidence rate of breast cancers in People's Republic of China has increased in the last decade, and many cases are responsive to hormone therapies. The third-generation aromatase inhibitor letrozole...
8.
He D, Li G, Gu X, Zhang L, Mao A, Wei J, et al.
Oncotarget
. 2015 Dec;
7(22):31814-24.
PMID: 26701723
Biotransformation by the endophytes of certain plants changes various compounds, and this 'green' chemistry becomes increasingly important for finding new products with pharmacological activity. In this study, polyphyllin VII (PPL7)...
9.
He D, Ma X
Acta Pharmacol Sin
. 2015 Dec;
37(1):19-24.
PMID: 26657058
The transient receptor potential (TRP) superfamily contains at least 28 homologs in mammalian. These proteins form TRP channels are permeable to monovalent and divalent cations and participate in a variety...
10.
He D, Xia Y, Gu X, Jin J, Ma X
J Pharm Biomed Anal
. 2014 Dec;
102:500-8.
PMID: 25459950
Although chemotherapy is widely used to treat human cancers, most chemotherapeutic agents only benefit a small fraction of patients because of the heterogeneity of cancers. Therefore, identifying of the sensitivity...